Regulus Therapeutics (RGLS): Turnaround Starting To Happen - Wedbush
Tweet Send to a Friend
Wedbush analyst, Liana Moussatos, reiterated her Outperform rating on shares of Regulus Therapeutics (NASDAQ: RGLS) after recent volatility on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE